Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.

@article{Rietman2006LongTT,
  title={Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.},
  author={Johan S. Rietman and Jan Hb Geertzen and Harald Joan Hoekstra and Peter C. Baas and Wil V Dolsma and Jakob de Vries and Jaap W. Groothoff and Willem H Eisma and Pieter Dijkstra},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2006},
  volume={32 2},
  pages={148-52}
}
BACKGROUND In a prospective study, long term upper-limb morbidity, perceived disabilities in activities of daily life (ADL) and quality of life (QOL) were assessed before and 2 years after sentinel lymph node biopsy (SLNB) or axillary lymph node dissections (ALND) for breast cancer. METHODS Two hundred and four patients with stage I/II breast cancer, mean age 55.6 years (SD: 11.6) entered the study and 181 patients (89%) could be evaluated after 2 years. Fifty-seven patients underwent SLNB… CONTINUE READING